| Product Name | Sitagliptin |
|---|---|
| CAS Number | 486460-32-6 |
| Molecular Formula | C16H15F6N5O |
| Molecular Weight | 407.31 g/mol |
| Appearance | White to off-white crystalline powder |
| Assay (HPLC) | ≥99% |
| Loss on Drying | ≤0.5% |
| Residue on Ignition | ≤0.1% |
| Heavy Metals | ≤10 ppm |
| Melting Point | ~203-207°C |
| Specific Rotation | [α]D20 = -10° to -12° (c=1, methanol) |
| Specification | 99% |
Need help? Contact our team

Sitagliptin is one of the most widely prescribed DPP-4 inhibitors on the market, and for good reason: it helps type 2 diabetes patients manage blood glucose without the dramatic peaks and troughs that come with some older therapies. By selectively blocking the DPP-4 enzyme, it extends the half-life of incretin hormones like GLP-1, which in turn boosts insulin release when glucose is high and keeps glucagon secretion in check. The result is a smoother, more physiological control of post-meal blood sugar—exactly what clinicians and patients are looking for.
We supply sitagliptin as a high-purity API (≥99% by HPLC) in its base form, ideal for formulation into oral tablets or combination therapies. Every batch is manufactured under strict quality controls and shipped with a complete COA, so you know exactly what you’re getting. Whether you’re planning a small pilot run or gearing up for commercial-scale production, we can match your volume—from 1 kg to metric tons—with reliable lead times and global logistics.
Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China